Otsuka ICU Medical today announced plans to invest more than $500 million to expand its U.S. IV solutions manufacturing in Texas. The companies (Otsuka Pharmaceutical Factory and ICU Medical), which launched this joint venture last year, plan to deliver a new facility and significant upgrades to its existing operations in Austin, Texas. They expect the…
Evonik to invest $100M in US drug contract manufacturing site
Evonik announced today that it plans to invest $100 million to expand its pharmaceutical manufacturing capabilities in the U.S. The Essen, Germany-based company is investing in its Tippecanoe Labs site in Lafayette, Indiana, which houses one of the world’s largest facilities for the production of active pharmaceutical ingredients (APIs). Over the next five years, the…
Codis acquires oral solid dose plant from Catalent
Codis announced today that it agreed to acquire an oral solid dose (OSD) development and manufacturing plant from Catalent. Acquiring the Nottingham, UK-based facility will add OSD development and small-scale manufacturing capabilities to Codis’ offerings, enabling it to offer a single partner path for integrated spray dry solutions. It can now provide development through clinical…
Besins Healthcare acquires pharmaceutical manufacturing company UniD
Besins Healthcare announced today that it acquired UniD Manufacturing, a Belgium-based pharmaceutical development and manufacturing company. UniD specializes in long-acting drug-delivery technologies, bringing decades of expertise to Besins, which delivers a range of hormone therapies. The company works with advanced polymer technology for complex long-acting delivery systems, including implants and vaginal rings. The companies expect…
Schott Pharma invests $60M to expand vial production in Pennsylvania
Schott Pharma announced that it opened up new production lines for both standard and sterile ready-to-use (RTU) glass vials. The company invested more than $60 million, largely funded by the Biomedical Advanced Research and Development Authority (BARDA), to strengthen the resilience of the U.S. pharmaceutical supply chain. It hopes to ensure reliable domestic production of…
Niowave breaks ground on $75M isotope production facility
Niowave announced today that it broke ground on a new $75 million production facility in Lansing, Michigan. The isotope manufacturing plant significantly expands the company’s manufacturing footprint and strengthens the domestic supply of Actinium‑225 (Ac‑225), a critical isotope used in next‑generation targeted cancer therapies. The isotope supports targeted cancer therapies designed to destroy cancer cells…
Fujifilm Cellular Dynamics opens new stem cell manufacturing plant in Wisconsin
Fujifilm Cellular Dynamics announced that it opened a new headquarters and manufacturing facility in Madison, Wisconsin. The company expects its new site to quadruple its capacity for human-induced pluripotent stem cell (iPSC)-based research products and services manufacturing footprint. It also expects to expand capabilities across its research product portfolio. The new expansion comes as part…
Eli Lilly commits $4.5B to Indiana manufacturing sites, opens gene therapy plant
Eli Lilly (NYSE:LLY) announced today that it has committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S.,…
Thermo Fisher unveils new cell therapy manufacturing platform
Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts–based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…
AstraZeneca opens new API manufacturing plant in Dublin
AstraZeneca has officially opened its new active pharmaceutical ingredient (API) manufacturing facility in Dublin, Ireland. IDA Ireland, the foreign direct investment arm of the Irish government, said in a news release that the new facility brings advanced automation, AI and innovative new technologies into one place to continue to innovate in science and manufacturing. “Healthcare…









